))
AI’s and Spatial Biology’s Potential for Curing Cancer, w/ Nucleai CEO Avi Veidman
Manage episode 427147635 series 3503527
Content provided by Jeff Wilser. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeff Wilser or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
For over 20 years, Avi Veidman served in the Israeli intelligence forces, and he used AI to to map the world. In the military he used AI for national defense, and he learned its power.
He then realized that just as AI could map a battlefield, it could map cancer cells in biopsies and pathology slides.
Enter Nucleai, his company that’s using AI to improve the science of “spatial biology,” which can ultimately unlock new treatments and cures…with cancer on their radar.
Avi and I get into how this all works, the staggering potential, and the real-world challenges that need to be overcome.
Nucleai
Merck’s $14 million investment in Nucleai:
62 episodes
Share
